Support the monthly forecast, monthly reporting and analysis, the annual operating plan, and the strategic plan processes. Provide variance analysis and determine cause of change. Scope includes the p&l, balance sheet, and cash flow statements.
In this role, the selected candidate will work with Internal-use software capitalization team to develop and maintain a standardized template for accounting and forecasting Fixed Asset capitalization, amortization, impairment and retirement.
The chosen candidate will perform financial and business related research and analysis such as the preparation of forecasts and/or analysis of financial reports, records and trends develops and maintains spreadsheets and databases to facilitate analysis and reporting and is responsible for conducting and documenting financial analysis projects.
The Capital Calculations & Line of Business Capital Management team is part of the Enterprise Capital Management organization. The primary focus of our team is to analyze and communicate Regulatory and Economic Capital, including calculation of pro forma capital for any upcoming regulations (e.g., Fundamental Review of the Banking Book (FRTB)).
Assist on the overall Market Strategy for the company by preparing comprehensive financial proformas for any/all potential new store openings, store relocations, and/or store conversions/consolidations.
The Sr. Financial Analyst will be responsible for the preparation, analysis and reporting of Intermediate Product Sales (i.e. non-Grifols pharmaceutical branded products) and Operating Expenses for the corporate functions of the Global Commercial Bioscience division.
Prepare and analyze monthly SBU results including: communication of variance versus forecast and budget, new product reporting, price/volume analysis, standard margin analysis, average selling price analysis, cost center expense analysis.